Our Focus

A major reason the vast majority of drugs in clinical trials fail is that there are too many silos in the research process, blocking the necessary sharing of critical information and furthering the inability to relate clinical effects to basic research findings.

At Certara, we understand that much of what the industry is seeking today in translational science is cross-disciplinary approaches aimed at the movement and management of information. It’s about making information more accessible, sharing data across projects and across project teams, and bringing safety assessment of lead compounds into earlier stages of the drug development process - to better utilize corporate resources to improve the effectiveness of drug development.

Certara provides solutions in predictive science, communication, and informatics that facilitate bi-directional sharing of information, support communication between members of interdisciplinary research teams, and enable safety/tox assessments to be made earlier in the process, thus allowing for more effective management of attrition.